Encompass Health Corporation EHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 644.40M | 621.00M | 609.20M | 566.20M | 541.00M |
| Total Depreciation and Amortization | 356.90M | 346.50M | 336.00M | 327.90M | 319.50M |
| Total Amortization of Deferred Charges | 9.60M | 9.60M | 9.60M | 9.60M | 9.70M |
| Total Other Non-Cash Items | 291.70M | 280.60M | 267.30M | 267.60M | 245.00M |
| Change in Net Operating Assets | 1.10M | -45.20M | -22.00M | 4.30M | -6.80M |
| Cash from Operations | 1.30B | 1.21B | 1.20B | 1.18B | 1.11B |
| Capital Expenditure | -846.50M | -799.10M | -735.70M | -736.40M | -705.80M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.20M | -27.30M | -20.50M | -28.20M | -23.10M |
| Cash from Investing | -866.70M | -826.40M | -756.20M | -764.60M | -728.90M |
| Total Debt Issued | 1.41B | 1.32B | 570.00M | 210.00M | 170.00M |
| Total Debt Repaid | -1.26B | -1.16B | -489.00M | -239.00M | -328.30M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -311.00M | -278.00M | -228.60M | -178.00M | -109.10M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -76.90M | -75.20M | -73.40M | -71.10M | -69.10M |
| Other Financing Activities | -194.10M | -195.40M | -182.30M | -153.10M | -148.20M |
| Cash from Financing | -430.50M | -390.00M | -403.30M | -431.20M | -484.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.50M | -3.90M | 40.60M | -20.20M | -105.20M |